Risk factors for early surgical intervention in neonates with gastroesophageal reflux disease
DOI:
https://doi.org/10.47338/jns.v11.1033Keywords:
Gastroesophageal reflux, Nissen Fundoplication, Antireflux surgery, Life-threatening complicationsAbstract
Background: Surgical intervention in neonates with Gastro-esophageal Reflux Disease (GERD) is usually reserved for failure of medical management or those having life-threatening complications of GERD. The optimal timing of intervention is still debatable. We aimed to identify the high-risk neonates with GERD requiring early surgical intervention.
Methods: This prospective cohort study was conducted at NICU and Pediatric Surgery Department, Ain Shams University, from June 2017 to June 2020, and enrolled the neonates and infants below 2 months with symptoms and signs suggestive of GERD. Demographic data, clinical history, medical management, need for antireflux surgery, and outcomes were recorded.
Results: In this study, 40 patients were enrolled and all were started on medical treatment. After the failure of medical management or life-threatening complications, 12 of these underwent anti-reflux surgery. In the medical group, six patients suffered from major complications (bronchopulmonary dysplasia and sepsis) and four mortalities. In the surgical group, three mortalities related to the development of bronchopulmonary dysplasia due to prolonged ventilation prior to surgery were recorded. The need for surgical intervention was significantly associated with younger gestational age (p = 0.001), younger age at presentation (p = 0.006), and lower weight at presentation (p = 0.034).
Conclusion: Medical treatment of more than 35 days with unsatisfactory response, low birth weight, gestational age (≤32 weeks), and NICU admission in the first 10 days of life are considered high-risk factors for early anti-reflux surgery in neonates.
Downloads
Metrics
References
Ferreira CT, Carvalho Ed, Sdepanian VL, Morais MB, Vieira MC, Silva LR. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice. J Pediatr 2014; 90:105-18.
Czinn SJ, Blanchard S. Gastroesophageal reflux disease in neonates and infants: when and how to treat. Paediatr Drugs 2013; 15:19-27.
Richard R, Foster JP, Psaila K. Continuous versus bolus intragastric tube feeding for preterm and low birth weight infants with gastro-oesophageal reflux disease. Cochrane Database Syst Rev 2014; 17:(7):CD009719.
Yoo BJ, Yang HK, Lee YJ. Fundoplication in Neonates and Infants with Primary Gastroesophageal Reflux. Pediatr Gastroenterol Hepatol Nutr 2014; 17(2): 93-7.
Jancelewicz T, Lopez ME, Downard CD, Islam S, Baird R, Rangel SJ, et al. Surgical management of gastroesophageal reflux disease (GERD) in children: A systematic review. J Pediatr Surg 2017; 52:1228-38.
Mullassery D, Jones MO. Gastro-esophageal reflux in children: surgical management. Surg 2019; 37: 204-7.
LaRiviere CA, Parimi C, Huaco JC, Acierno SA, Garrison MM, Goldin AB. Variations in preoperative decision making for antireflux procedures in pediatric gastroesophageal reflux disease: a survey of pediatric surgeons. J Pediatr Surg. 2011; 46:1093-8.
Maqbool A, Ryan MJ. Gastroesophageal Reflux Disease and Aerodigestive Disorders. Curr Probl Pediatr Adolesc Health Care. 2018; 48: 85-98.
Pacilli M, Chowdhury MM, Pierro A. The surgical treatment of gastro-esophageal reflux in neonates and infants. Semin Pediatr Surg. 2005; 14(1): 34-41.
Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr 2005; 146:3-12.
Srivastava R, Berry JG, Hall M, Downey EC, O’Gorman M, Dean JM, et al. Reflux related hospital admissions after fundoplication in children with neurological impairment: retrospective cohort study. BMJ. 2009; 339: b4411.
Macharia EW, Eaton S, de Coppi P, Curry J, Drake D, Cross K, et al. Fundoplication in Ventilator-Dependent Infants with Gastro-oesophageal Reflux. Eur J Pediatr Surg 2012; 22:91–6.
Hassall E. Over-prescription of acid-suppressing medications in infants: how it came about, why it’s wrong, and what to do about it. J Pediatr. 2012; 160:193-8.
Terrin G, Passariello A, De Curtis M, Manguso F, Salvia G, Lega L, et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatr 2012; 129:e40-5.
Day CL, Ryan RM. Bronchopulmonary dysplasia: new becomes old again. Pediatr Res 2017; 81: 210-13.
Lightdale JR, Gremse DA. Section on Gastroenterology, Hepatology, and Nutrition. Gastroesophageal reflux: management guidance for the pediatrician. Pediatrics 2013; 131:e1684-95.
Jadcherla SR, Slaughter JL, Stenger MR, Klebanoff M, Kelleher K, Gardner W. Practice Variance, Prevalence, and Economic Burden of Premature Infants Diagnosed With GERD. Hosp Pediatr 2013; 3:335-41.
Kimber C, Kiely EM, Spitz L. The failure rate of surgery for gastro-oesophageal reflux. J Pediatr Surg 1998; 33:64-6.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Shady S Shokry, Khaled M El-Asmar, Mohamed M Dahab, Tarek A Hassan
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
